ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 265 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $14,127,000 | -60.5% | 1,143,920 | -53.5% | 1.61% | -38.8% |
Q4 2017 | $35,808,000 | -34.8% | 2,461,034 | -36.2% | 2.64% | -40.6% |
Q3 2017 | $54,879,000 | -22.0% | 3,856,622 | -30.0% | 4.44% | +0.4% |
Q2 2017 | $70,348,000 | -14.2% | 5,513,222 | -14.8% | 4.43% | -30.2% |
Q1 2017 | $82,007,000 | +4.9% | 6,467,430 | -15.6% | 6.35% | +14.5% |
Q4 2016 | $78,207,000 | -42.9% | 7,659,841 | -26.4% | 5.54% | -32.7% |
Q3 2016 | $137,026,000 | -21.4% | 10,404,446 | -24.2% | 8.23% | -34.7% |
Q2 2016 | $174,369,000 | +25.6% | 13,729,919 | +30.7% | 12.60% | +49.6% |
Q1 2016 | $138,799,000 | -2.7% | 10,507,149 | +13.3% | 8.42% | -20.5% |
Q4 2015 | $142,634,000 | +11.2% | 9,274,026 | -10.3% | 10.59% | +5.4% |
Q3 2015 | $128,249,000 | +27.2% | 10,342,615 | +40.4% | 10.05% | +41.4% |
Q2 2015 | $100,789,000 | +44.8% | 7,367,654 | +26.6% | 7.11% | +29.6% |
Q1 2015 | $69,611,000 | +79.8% | 5,820,367 | +92.0% | 5.48% | +80.4% |
Q4 2014 | $38,709,000 | – | 3,031,245 | – | 3.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |